4//SEC Filing
HENDERSON REBECCA M 4
Accession 0001567619-20-010595
CIK 0000874716other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:03 PM ET
Size
13.8 KB
Accession
0001567619-20-010595
Insider Transaction Report
Form 4
HENDERSON REBECCA M
Director
Transactions
- Exercise/Conversion
Common Stock
2020-05-13$64.69/sh+5,974$386,458→ 20,670 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2020-05-13−5,974→ 0 totalExercise: $64.69Exp: 2024-05-06→ Common Stock (5,974 underlying) - Sale
Common Stock
2020-05-13$286.66/sh−5,974$1,712,487→ 14,696 total - Exercise/Conversion
Common Stock
2020-05-13$63.95/sh+7,422$474,637→ 22,118 total - Sale
Common Stock
2020-05-13$286.66/sh−7,422$2,127,565→ 14,696 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2020-05-13−7,422→ 300 totalExercise: $63.95Exp: 2025-05-05→ Common Stock (7,422 underlying)
Footnotes (3)
- [F1]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,861 shares on May 6, 2016, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F3]Not spplicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001254748
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:03 PM ET
- Size
- 13.8 KB